Dana-Farber Cancer Institute; Rheumatology

Boston, Massachusetts 02215-5501

0 studies enrolling now · 1 studies all time

What they study most

Lupus Erythematosus, Systemic

Studies at this site

• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus — Completed